H2L5186303

CAS No. 139262-76-3

H2L5186303( ZINC33388081 )

Catalog No. M27634 CAS No. 139262-76-3

H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 88 Get Quote
10MG 160 Get Quote
25MG 357 Get Quote
50MG 530 Get Quote
100MG 759 Get Quote
500MG 1557 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    H2L5186303
  • Note
    Research use only, not for human use.
  • Brief Description
    H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment.
  • Description
    H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment.(In Vitro):The high cell invasion activity of HT1080-M6 cells is significantly suppressed by H2L5186303.(In Vivo):H2L5186303 shows strong suppressive efficacy when administered before OVA sensitization and challenge, such as suppression of airway hyper responsiveness, inflammatory cytokine levels, mucin production, and eosinophil numbers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ZINC33388081
  • Pathway
    GPCR/G Protein
  • Target
    LPA Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    139262-76-3
  • Formula Weight
    488.45
  • Molecular Formula
    C26H20N2O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (511.82 mM)
  • SMILES
    O(C1=CC(OC2=CC=C(NC(/C=C\C(O)=O)=O)C=C2)=CC=C1)C3=CC=C(NC(/C=C\C(O)=O)=O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gibson Francis S. Synthesis of paclitaxel by protecting the 7-?hydroxyl of baccatin III using a strong base and an electrophile. WO9945001A1.
molnova catalog
related products
  • BMS-986278

    BMS-986278 is an orally active and potent hemophosphatidic acid receptor 1 (LPA1) antagonist with Kb values of 6.9 nM and 4.0 nM for human and mouse LPA1, respectively.

  • HG-14-10-04

    HG-14-10-04 is a potent and specific ALK inhibitor.

  • ONO-7300243

    ONO-7300243 is an antagonist of lysophosphatidic acid receptor 1 (LPA1; IC50 : 0.16 μM).